India Approves QDENGA Dengue Vaccine for People Aged 4–60 India has approved Takeda’s QDENGA as its first authorised dengue vaccine for people aged 4–60. The live-attenuated vaccine targets all four dengue virus serotypes and is administered in two doses, three months apart. India has approved QDENGA, making it the country’s first authorised vaccine for preventing dengue. The Drug Controller General of India has granted market authorisation for its use am
India Approves QDENGA Dengue Vaccine for People Aged 4–60 India has approved Takeda’s QDENGA as its first authorised dengue vaccine for people aged 4–60. The live-attenuated vaccine targets all four dengue virus serotypes and is administered in two doses, three months apart. India has approved QDENGA, making it the country’s first authorised vaccine for preventing dengue. The Drug Controller General of India has granted market authorisation for its use am
Kadapa Covid Cases Prompt Increased Health Surveillance in Andhra Pradesh Updated: July 15, 2026, Andhra Pradesh has strengthened Covid-19 surveillance after two people who tested positive for the virus died and eight active cases were reported in YSR Kadapa district. State health officials have described the infections as sporadic and said the situation should not be treated as evidence of a fresh outbreak. Rapid response teams hav
Kadapa Covid Cases Prompt Increased Health Surveillance in Andhra Pradesh Updated: July 15, 2026, Andhra Pradesh has strengthened Covid-19 surveillance after two people who tested positive for the virus died and eight active cases were reported in YSR Kadapa district. State health officials have described the infections as sporadic and said the situation should not be treated as evidence of a fresh outbreak. Rapid response teams hav